Evaluation of the GORE TIGRIS Vascular Stent
Public ClinicalTrials.gov record NCT01576055. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of the GORE TIGRIS Vascular Stent in the Treatment of Atherosclerotic Lesions of the Superficial Femoral and Proximal Popliteal Arteries
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the randomized study is to evaluate the safety and effectiveness of the TIGRIS Vascular Stent in the treatment of de novo and restenotic atherosclerotic lesions, ≤ 24cm in length, in the superficial femoral and proximal popliteal arteries (SFA/PPA) of patients with symptomatic peripheral arterial disease (PAD).
Study identification
- NCT ID
- NCT01576055
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 267 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2012
- Primary completion
- Jul 31, 2015
- Completion
- Jul 31, 2017
- Last update posted
- Oct 8, 2017
2012 – 2017
United States locations
- U.S. sites
- 34
- U.S. states
- 20
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cardiology Associates of Mobile | Mobile | Alabama | 36532 | — |
| Arkansas Heart | Little Rock | Arkansas | 72211 | — |
| North County Radiology | Oceanside | California | 92056 | — |
| UC Davis Vascular Center | Sacramento | California | 95817 | — |
| Kaiser Permanente San Francisco | San Francisco | California | 94118 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06520 | — |
| First Coast Cardiovascular Institute, P.A | Jacksonville | Florida | 32216 | — |
| MediQuest Research at Munroe Regional | Ocala | Florida | 34471 | — |
| Orlando Regional Healthcare System | Orlando | Florida | 32806 | — |
| Coastal Vascular & Interventional | Pensacola | Florida | 32504 | — |
| Vascular Surgical Associates, PC | Austell | Georgia | 30106 | — |
| Medical Center of Central Georgia | Macon | Georgia | 31201 | — |
| Kaiser Permanente - Honolulu | Honolulu | Hawaii | 96817 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Alexian Brothers Specialty Group | Elk Grove Village | Illinois | 60007 | — |
| Heart Care Research Foundation | Mokena | Illinois | 60448 | — |
| Advocate Christ Medical Center | Oak Lawn | Illinois | 60453 | — |
| HeartCare MidWest - Peoria | Peoria | Illinois | 61614 | — |
| Indiana University Vascular Surgery | Indianapolis | Indiana | 46202 | — |
| Genesis Medical Center | Davenport | Iowa | 52803 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| Minneapolis Radiology and Vascular | Minneapolis | Minnesota | 55441 | — |
| SSM Health Care | Saint Charles | Missouri | 63301 | — |
| Vascular Research Institute | Morristown | New Jersey | 07960 | — |
| Ohio Health Research Institute | Columbus | Ohio | 43214 | — |
| Providence Heat & Vascular Institute | Portland | Oregon | 97225 | — |
| Heritage Valley Health System | Beaver | Pennsylvania | 15009 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| The Miriam Hospital | Providence | Rhode Island | 02906 | — |
| North Central Heart Institute, Ltd. | Sioux Falls | South Dakota | 57108 | — |
| Baylor Research Institute | Dallas | Texas | 75093 | — |
| Presbyterian Hospital, Dallas | Dallas | Texas | 75231 | — |
| CAMC Health Education and Research Institute, Inc. | Charleston | West Virginia | 25304 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Peripheral Arterial Disease trials
Other public records listing Peripheral Arterial Disease. Sorted by last update posted; newest first. Not a recommendation.
- NCT00424866: FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease Not yet recruiting
- NCT07619885: The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate）and Plavix® in Healthy Participants Recruiting
- NCT06319339: Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease Recruiting
- NCT07223593: Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease Recruiting
- NCT05811364: The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease Recruiting
- NCT07335341: Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01576055, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 8, 2017 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01576055 live on ClinicalTrials.gov.